September 4-5, 2019
Vail, Colorado
Hosted by: Colorado BioScience Association
The Rocky Mountain Life Science Investor & Partnering Conference returns to Vail, CO September 4-5 2019 to bring together leading investors and strategic partners from across the U.S. and the region's top life science companies to cultivate partnerships and source investment opportunities in the areas of medical device, diagnostic, biotech, pharma and digital health.
Cambridge Healthtech Institute’s 8th Annual “Clinical Technology and Innovation” conference will feature a broad array of topics such as blockchain technology, machine learning, digital trends, and their adoption and implementation in clinical research. We are looking forward to hosting a practical and productive knowledge and experience exchange.
Over two days, the Ai4 Healthcare conference brings together business leaders, data practitioners, and AI pioneers who are applying artificial intelligence to solve problems and create opportunities in the healthcare industry. Thanks to the convergence of modern computing power and data science, the healthcare industry is leveraging AI to create entirely new value.
Programmatic technology, patient centricity, machine learning, GDPR and big data - healthcare marketing is scrambling to keep up with change at every level. If we get it right, we will speed cures to market and enable consumers to be active participants in their healthcare. If we get it wrong, we will continue to enable a broken global healthcare system.
The Medical Innovation Summit brings together thought leaders and their passion about healthcare. And it is our goal to not only connect these individuals but to celebrate the innovation that is happening here and around the world. Discussions are curated with the goal of igniting the disruption our patients need now.
Programmatic technology, patient centricity, machine learning, GDPR and big data - healthcare marketing is scrambling to keep up with change at every level. If we get it right, we will speed cures to market and enable consumers to be active participants in their healthcare. If we get it wrong, we will continue to enable a broken global healthcare system.
Artificial intelligence. Machine Learning. Along with Blockchain, you can’t attend a healthcare gathering without hearing those words. AI/ML are seemingly being applied to every part of healthcare from discovery to delivery to marketing. The Triple Aim is what we strive for in healthcare: to decrease cost, improve the patient experience and increase quality of care. How will AI/ML help us achieve those objectives where other tools can’t?
Join your peers and build a roadmap to enhance your digital strategy and develop a better customer experience. Learn how you can enhance the patient journey through partnerships with payers, providers and pharmacies, how data and technology can aid with decision making, and how design thinking and behavioral-science approaches can help define the user experience.
The World Medical Innovation Forum is a global gathering of more than 1,000 senior healthcare leaders in the heart of Boston. It was established to respond to the intensifying transformation of healthcare and its impact on innovation. The Forum is rooted in the belief that no matter the magnitude of that change, the center of healthcare needs to be a shared, fundamental commitment to collaborative innovation – industry and academia working together to improve patient lives.
Remedy Health Media (Remedy) and New York City Health Business Leaders (NYCHBL) announced today the winners of the 2017 Boldest Digital Health Influencers Awards. The awards are held each year to recognize the contributions of top personalities influencing the digital health field across three categories: Patient Advocate, Agency Guru and Brand Marketer.
Clinical trials are changing—and changing rapidly. From greater patient involvement, integration of cost-effectiveness considerations in trial design, increasing pressure to make drug available faster, and inclusion of new sources of data, there are new opportunities to collect, curate, and integrate more data and new sensibilities. But, these new opportunities also represent new challenges for supporting clinical trials in general—integrity of new data, relevance of new sources, applicability, noise versus signal, and the overall challenges of managing a greater variety of data in a complex environment.
Emmanuel Fombu, MD, MBA, is a physician, author, speaker and healthcare executive turned Silicon Valley entrepreneur.
Dr. Fombu champions the potential for the internet of things, artificial intelligence and machine learning to revolutionize the healthcare industry.